Vector Science & Therapeutics Corp. (PAIN.V)

Assistant

Ask questions, navigate pages, or type / for commands

Ask

Navigate

Command

Vector Science & Therapeutics Corp. PAIN.V

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX-V · United States · vectorscience.co

Vector Science and Therapeutics develops novel biomechanical devices and active localized drug-delivery platforms for site-directed interventions in musculoskeletal tissue regeneration, including transdermal drug delivery. Based in Mequon, Wisconsin, the company listed on the TSX Venture Exchange in April 2026 (formerly OpenSesame Acquisition Corp.) and has a development and manufacturing agreement with MPP Group LLC for pharmaceutical-grade peptides and drug delivery devices.

Key ratios

ReturnOnAssets TTM -0.19

ReturnOnAssets 2025 -0.19

ReturnOnEquity TTM -1.04

ReturnOnEquity 2025 -1.04

Recent news

Vector Science & Therapeutics Reports First Quarterly Financial Results as a Public Company; Announces Inaugural Investor Q&A on July 28 2026-07-24 · CNW

Vector Science & Therapeutics Announces Distributor Network Buildout to Support Its Peptide Portfolio Across Orthopedic, Sports, and Regenerative Medicine Channels 2026-07-21 · CNW

Vector Science & Therapeutics Builds 15-Patent-Application Intellectual Property Portfolio Around Precision Therapeutic Delivery, Anchored by Peptide and Biologic Administration Technologies 2026-07-15 · CNW

Vector Science & Therapeutics Announces Landmark Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus for Its Proprietary Peptide Portfolio 2026-07-07 · Newswire (CNW)